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To better understand the mechanisms by which zinc deficiency induces epithelial cell death,
studies were done of the effects of intracellular zinc depletion induced by the zinc chelator
TPEN on apoptosis-related events in human malignant epithelial cell lines LIM1215 (colonic),
NCI-H292 (bronchial), and A549 (alveolar type II). In TPEN-treated cells, depletion of zinc
was followed by activation of caspase-3 (as demonstrated by enzymatic assay and Western
blotting), DNA fragmentation, and morphologic changes. Increase in caspase-3 activity began
1–2 h after addition of TPEN, suggesting that zinc may suppress a step just before the acti-
vation of this caspase. Caspase-6, a mediator of caspase-3 processing, also increased, but later
than caspase-3. Effects of TPEN on apoptosis were completely prevented by exogenous ZnSO4
and partially prevented by peptide caspase inhibitors. A critical substrate of caspase-3 may
be the cell cycle regulator p21Waf1/Cip1, which was rapidly cleaved in TPEN-treated cells to a
15-kDa fragment before further degradation.
The group IIb zinc metal is an important factor in resistance
to infectious agents as evident from the increased rates of in-
fections in zinc-deficient animals and humans (reviewed in 1-
3). Zinc may mediate resistance to infection at two levels: first,
via a beneficial effect on the immune system where it promotes
the survival, proliferation, and function of T cells, especially
the Th1 subset; and, second, by protecting the epithelial tissues
from damage by oxidants and other noxious agents, thereby
facilitating innate immunity. Zinc deficiency can result in epi-
thelial lesions in the skin and gastrointestinal lining [4] and a
heightened susceptibility to damage by other toxins (e.g., in the
duodenum by colchicine [5]). One of the mechanisms of zinc
deficiency–induced epithelial damage is by increased death of
epithelial cells via the cell suicide process of apoptosis (gene-
directed cell death) [6]. Zinc deficiency can also result in cell
death by necrosis, especially if the apoptotic pathway is dys-
functional [7]. The mechanisms by which zinc deficiency en-
hances apoptosis remain unclear. Therefore, in this study, we
attempted to better understand these mechanisms by using a
variety of epithelial cell lines induced to apoptose by in vitro
zinc deprivation.
A variety of antiapoptotic and proapoptotic proteins interact
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to regulate the pathways of apoptosis in cells. Among the major
proapoptotic proteins is the caspase family of aspartate-specific
proteases [8]. The caspase family of effector enzymes has been
implicated in many [8], although not all [9], biochemical path-
ways leading to apoptosis. Among the caspase-dependent forms
of apoptosis, three major pathways have been described [10,
11]. The first involves membrane receptor-ligand interactions
(e.g., Fas-FasL binding) and results in activation of the up-
stream caspase, caspase-8; the second pathway, often triggered
by chemical stimuli, causes changes in mitochondrial membrane
permeability, release of cytochrome c into the cytoplasm, and
subsequent activation of the upstream caspase, caspase-9; a
third pathway involves caspase-12 and is triggered in response
to stress-induced changes in the endoplasmic reticulum [11].
Both caspase-8 and caspase-9 trigger, indirectly or directly,
activation of the major effector caspase, caspase-3/DEVD-cas-
pase. This caspase-3 in turn cleaves after DXXD in poly (ADP-
ribose) polymerase and other substrates, triggering the distinc-
tive biochemical and morphologic changes associated with this
apoptotic cell death [8]. Hence, the detection of this enzyme is
critical and has led to the development of an enzymatic assay,
based on liberation of a fluorogenic coumarin derivative AFC
from the substrate DEVD-AFC [12]. Caspase-3 is activated by
cleavage of a 32-kDa zymogen (CPP32); cleavage results in the
formation of large and small subunits that rearrange to form
an active caspase [12]. Cleavage of the precursor form of cas-
pase-3 is mediated by other caspases, especially caspase-9 and
caspase-6 (previously known as Mch2a [13]). Caspase-9–de-
pendent cleavage of CPP32 is triggered by the release of cy-
tochrome c from mitochondria and is suppressed by Bcl-2 [10,
14]. The factors regulating caspase-6 cleavage of CPP32 are
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unknown. Therefore the biochemical pathways governing the
activation and processing of these caspases are a subject of
much interest.
Our laboratory [15] and others [16–18] recently identified one
of these targets as the universal cell cycle regulator p21Waf1/Cip1.
p21 is an inhibitor of various members of the cyclin-dependent
kinases (CDKs), which control the orderly progression of cells
through different cell cycle states [19]. p21 contains a domain
near its amino terminus that binds to cyclin/CDK complexes;
this interaction inhibits CDK activity and hinders its ability to
phosphorylate the retinoblastoma family of proteins. This, in
turn, is responsible for G1/S phase arrest induced by p53 in
response to DNA damage [19]. In addition to its N-terminal
CDK inhibitory domain, p21 contains a proliferating cell nu-
clear antigen (PCNA) binding motif located in the carboxy
terminal part of the protein that may be important for the
inhibition of DNA replication by p21 [20]. Recently, the cleav-
age of p21 by a caspase-3–like activity during apoptosis in
response to various stimuli was reported. These include cleav-
age of p21 in butyrate-treated LIM1215 cells [15], tumor ne-
crosis factor–induced apoptosis of human cervical carcinoma
cells [16], and growth factor–deprived human endothelial cells
[16] in response to DNA damage by g-irradiation and DNA-
damaging agents [18].
Here we sought to determine whether depletion of intracel-
lular zinc in various epithelial cell lines would influence acti-
vation of caspase-3 and caspase-6 and the cleavage of p21. We
used three human malignant epithelial cell lines: colonic epi-
thelial LIM1215 cells, bronchial epithelial NCI-H292 cells, and
alveolar type II epithelial A549 cells. These cell lines have been
widely used in our laboratory to dissect the biochemical path-
ways regulating apoptosis induced by various agents [21]. In-
tracellular zinc was depleted by use of the membrane-permeable
zinc chelator TPEN [22], and levels of this zinc were monitored
with a UV-excitable intracellular zinc (II)-specific fluorophore,
Zinquin [21, 22].
Methods and Materials
Materials. Major materials and their suppliers were: EDTA,
EGTA, herring sperm DNA, Nonidet P-40 (NP-40), dithiothreitol
(DTT), sucrose, HEPES (Sigma Chemical, St. Louis); complete
protease inhibitor cocktail (Boehringer Mannheim, Mannheim,
Germany); penicillin/streptomycin, EDTA/trypsin, RPMI 1640 cul-
ture medium, glutamine, CHAPS (ICN, Aurora, OH); gentamicin
(David Bull Laboratories, Melbourne); Coomassie brilliant blue
G-250 (BDH, Sydney); fetal bovine serum (FBS; Biosciences, Syd-
ney); zDEVD-AFC, zVAD-fmk, zDEVD-fmk (Kamiya Biomedi-
cal, Tukwila, WA); VEID-AFC (Calbiochem NSW, Alexandria,
Australia); Zinquin, ethyl-[2-methyl-8-p-toluenesulphonamido-6-
quinolyloxy]acetate [23] was obtained from A. D. Ward, Depart-
ment of Chemistry, University of Adelaide, South Australia), dis-
solved in DMSO as a 5 mM stock solution and stored in aliquots
at 2207C in the dark. All other reagents were reagent grade, unless
indicated.
Cell cultures. LIM1215 cells were obtained from R. Whitehead
(Ludwig Institute, Melbourne), while A549 and NCI-H292 cells
were obtained from D. Knight (QEII Medical Centre, Perth, West-
ern Australia). Cell lines were cultured in RPMI 1640, buffered in
HEPES at pH 7.4, and supplemented with glutamine (2 mM),
penicillin (100 IU/mL), streptomycin (100 mg/mL), gentamicin (160
mg/mL), and 10% FBS in a humidified atmosphere containing 5%
CO2. Experiments were performed either in 25-cm
2 vented tissue
culture flasks or 6-well plates (Sarstedt, Newton, NC). Cells were
allowed to attach and grow for 2–3 days to confluence prior to
exposure to test reagents. TPEN was added from a stock solution
of 5 mM in DMSO to give the final indicated concentration. The
final concentration of DMSO was <0.5% after addition of TPEN.
Quantification of Zinquin fluorescence by image analysis. Cells
were grown to semiconfluence on sterile glass coverslips in 6-well
plates for 48 h before the addition of Zinquin. Coverslips were then
washed in PBS and incubated with 25 mM Zinquin in PBS for 30
min at 377C. Coverslips were inverted on microscope slides. Flu-
orescence was examined by a microscope (BH2; Olympus, Tokyo)
equipped with epifluorescence, UV B dichroic mirror for low wave-
length excitation, and connected to a Panasonic CCTV video color
camera suitable for low light fluorescence with integration capa-
bilities and a computer work station. Both fluorescence images and
corresponding phase contrast microscope images were captured
and stored using a 203 objective lens. With the VideoPro (Leading
Edge) image analysis system, lines were drawn around the borders
of cells, and fluorescence intensity within the borders was measured.
For all images, background illumination in an area not occupied
by cells was subtracted from the readings.
Apoptotic DNA fragmentation. To assay DNA fragmentation,
cells ( –107 in total) were lysed at 47C in 1 mL of NP-4065 3 10
lysis buffer (5 mM Tris-HCl, pH 7.5, containing 5 mM EDTA and
0.5% NP-40) and centrifuged at 13,000 g for 10 min at 47C. Su-
pernatant fractions containing low-molecular-weight DNA frag-
ments were assayed for DNA by a fluorometric technique [24].
Hoechst dye 33258 was dissolved in deionized water to a concen-
tration of 1 mg/mL and stored at 47C. Prior to use, 1 mL of dye
was added per 10 mL of buffer (10 mM Tris-HCl, pH 7.4, con-
taining 1 mM EDTA and 100 mM NaCl). Aliquots of lysate (20–50
mL) were placed into fluorimeter-grade disposable cuvettes (Grei-
ner, Kremsmunster, Austria) and 1 mL of diluted dye solution was
added. Fluorescence was measured at an excitation wavelength of
356 nm and emission wavelength of 458 nm (slit widths, 10 nm)
in a fluorescence spectrophotometer (LS50; Perkin-Elmer, Nor-
walk, CT). Herring sperm DNA was used to derive a standard
curve.
Measurement of DEVD-caspase (caspase-3) and VEID-caspase
(caspase-6) activities. DEVD-caspase was assayed by cleavage
of DEVD-AFC (asp-glu-val-asp-7-amino-4-trifluoro-methyl-cou-
marin), a fluorogenic substrate based on the peptide sequence at
the caspase-3 cleavage site of poly (ADP-ribose) polymerase [12].
VEID-caspase was assayed by cleavage of VEID-AFC (val-glu-ile-
asp-7-amino-4-trifluoro-methyl-coumarin), a fluorogenic substrate
based on the peptide sequence at the caspase-6 cleavage site of
lamin [13]. Cells ( 6–107 per flask) were cultured with test5 3 10
reagents, washed once with 5 mL of HBSS, and resuspended in 1
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Figure 1. Depletion of zinc (Zn) in epithelial cells as shown by
Zinquin fluorescence. Images of Zinquin fluorescence of intracellular
zinc in A549 (upper panels) and NCI-H292 cells (lower panels). Right
panels demonstrate basal Zinquin fluorescence of untreated cells (weak
for A549 and moderate for NCI-H292 cells). Left panels show
quenched fluorescence following intracellular zinc depletion using
TPEN. Note linear color scale of 0–255 pixels.
mL of NP-40 lysis buffer (as for DNA fragmentation). After 15
min in lysis buffer at 47C, insoluble material was pelleted at 15,000
g and an aliquot of the lysate was tested for protease activity. To
each assay tube, we added 10–20 mL of cell lysate and then 1 mL
of protease buffer (50 mM Hepes, 10% sucrose, 10 mM DTT, 0.1%
CHAPS, pH 7.4) containing 8 mM of substrate. After 4–18 h at
room temperature, fluorescence was quantified (excitation 400,
emission 505) in the LS50 spectrofluorometer. Optimal amounts of
added lysate and duration of assay were taken from linear portions
of curves as determined in preliminary experiments. One unit of
caspase activity was considered to be 1 fluorescence U (at slit widths
of 5 nm) per microgram of lysate protein.
Flow cytometric assay for apoptosis. Cells were removed from
culture dishes by trypsinization, collected by centrifugation, resus-
pended in ice-cold PBS, and fixed in absolute methanol for >30
min. Cells were then washed in PBS containing 0.5% Tween 20,
followed by two washes in PBS containing 2% fetal calf serum
(FCS). After the washes, cells were resuspended in PBS/2% FCS
containing 40 mg/mL RNase A and incubated for 20 min at 377C.
Finally, cells were washed in PBS/2% FCS and resuspended in PBS
containing propidium iodide (20 mg/mL). The stained nuclei were
analyzed by flow cytometer (Epics Profile; Coulter, Hialeah, FL).
Cell cycle distribution was based on 2N and 4N DNA content.
Cells with !2N DNA content were indicative of apoptotic cells. A
linear measurement scale was used for quantification.
Morphologic assessment of apoptosis. Apoptosis was also as-
sessed in some experiments by chromatin condensation in hema-
toxylin eosin (HE)–stained cell cultured coverslips and by labeling
of nuclear fragments with Hoechst dye 33258 (1 mg/mL). One thou-
sand cells were scored from replicate tubes.
Protein assay. Protein concentration was measured by the DC
protein assay kit (BioRad Laboratories, Hercules, CA) in accor-
dance with the manufacturer’s instructions.
Western blotting. Cell aliquots were lysed in NP-40 lysis buffer
(5 mM Tris-HCl, pH 7.5, containing 5 mM EDTA, 0.5% NP-40,
and complete protease inhibitor cocktail) and stored at 2207C until
assayed. One volume of 43 SDS-loading buffer (250 mM Tris-
HCl, pH 6.8, 40% [vol/vol] glycerol, 8% [wt/vol] SDS, 20% [vol/
vol] 2-mercaptoethanol, and 0.5% [wt/vol] bromophenol blue) was
added to three volumes of lysate and mixtures were denatured.
Equal protein amounts (18–36 mg) were loaded into wells and elec-
trophoresed on 12% minigels (Bio-Rad) at 200 V for 45 min. To
ensure that equal amounts of protein were loaded in each track,
duplicate gels were also stained with Coomassie brilliant blue G-
250. Proteins were blotted onto Immobilon-P polyvinylidene di-
fluoride membrane (Millipore, Sydney). Membranes were pre-
blocked with 3% powdered milk in Tris-buffered saline/0.1% Tween
20 and 3% bovine serum albumin for 60 min at room temperature.
Primary antibodies used were mouse monoclonal anti-human
p21 (clone 6B6, 1/333 dilution; PharMingen, San Diego), goat poly-
clonal anti-human Mch2 p20 (K-20) IgG (1/500 dilution, Santa
Cruz Biotech, Santa Cruz, CA) and goat polyclonal anti-human
CPP32 p20 (N-19) IgG (1/1000 dilution, Santa Cruz Biotech). Sec-
ondary antibody was either sheep anti-mouse IgG peroxidase con-
jugate (1/1000 dilution, Fab fragment; Boehringer Mannheim) or
anti-goat IgG peroxidase conjugate (1/1000 dilution, whole anti-
body, Santa Cruz Biotech). Primary antibodies were added for 60
min and secondary antibodies for 45 min at room temperature.
Membranes were then soaked in enhanced chemiluminescence
Western blotting reagent (Amersham Life Sciences, Sydney), and
bands were detected by chemiluminescence. Rainbow high-molec-
ular-weight markers (Amersham Life Sciences) were used for de-
termination of molecular weight.
Experimental design. All experiments were repeated a mini-
mum of three times. Statistical significance was determined by Stu-
dent’s t test and as indicated in text or figure legends.
Results
Intracellular zinc depletion by TPEN as demonstrated by de-
crease in Zinquin fluorescence. In order to deplete intracellular
zinc, cell lines were treated with varying concentrations of the
membrane-permeable zinc chelator TPEN. Intracellular zinc
content (specifically the more labile pools of zinc) were mon-
itored by loading the cells with the zinc-specific fluorophore
Zinquin. Figure 1 shows the strong quenching of Zinquin flu-
orescence by TPEN in two of these cell lines, A549 (upper
panels) and NCI-H292 (lower panels). The panel on the right
in figure 1 represents the normal zinc content of the cells, while
the panels on the left show the zinc-depleted cells after addition
of TPEN for 1 h. Zinquin fluorescence was significantly
quenched by TPEN, which has a much higher affinity for zinc
than Zinquin [22]. Thus, in NCI-H292 cells, specific mean flu-
orescence intensity decreased from pixels ( )23.1 5 2.2 n p 29
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Figure 2. TPEN-induced activation of DEVD-caspase activity. A,
LIM 1215 cells were treated with varying concentrations of TPEN for
3 h (m); other cell lines were treated for 4 h (A549, n; NCI-H292, M).
B, Cells were treated for varying times with 25 mM TPEN. Cell lysates
were assayed for DEVD-caspase activity. Typical experiment is shown
for LIM1215 and NCI-H292 cells. Data are means of triplicates; error
bars indicate SDs. For A549 and NCI-H292 cells, data were collated
from 3 experiments, each in triplicate.
Figure 3. TPEN-induced activation of caspase-3 and caspase-6 by
Western blotting. LIM1215 cells were treated with 25 mM TPEN for
varying times (<6 h). Cell lysates were prepared and assayed for cas-
pase-3 (A) or caspase-6 (B) by Western blotting. Antibody for caspase-
3 detected only 32-kDa precursor (CPP32). Antibody for caspase-6
detected the active p20 subunit. Typical experiments are shown.
in cells incubated with Zinquin alone to pixels9.7 5 0.7
( ) in cells incubated with Zinquin 1 25 mM TPENn p 28
( ); in A549 cells, fluorescence decreased fromP < .005 11.8 5
pixels ( ) in cells incubated with Zinquin alone to0.3 n p 192
pixels ( ) in cells incubated with Zinquin 17.2 5 0.3 n p 187
25 mM TPEN ( ).P < .05
Zinc depletion induces caspase-3 activation and DNA frag-
mentation. To determine the effects of zinc depletion on cas-
pase-3 activation, epithelial cells were treated with varying con-
centrations of TPEN for 4 h. Cell lysates were prepared and
assayed for DEVD-caspase activity (figure 2A). In each of the
three cell lines, there was a significant increase in DEVD-cas-
pase activity, especially at TPEN concentrations >12.5 mM.
Thus, in LIM1215 cells (figure 2A,), there was a small but
significant ( ) increase in DEVD-caspase activity withP < .05
6.25 mM TPEN, followed by highly significant increases (P <
) at 12.5 and 25 mM TPEN (the latter yielding a maximal.005
response).
The kinetics of these increases were studied using 25 mM
TPEN. DEVD-caspase activity increased slowly between 1 and
2 h after addition of TPEN in both cell lines studied (NCI-
H292 and LIM1215, figure 2B). After 2 h, there were sharp
rises in DEVD-caspase activity, increasing linearly up to 6 h
(the latest time point tested). The induction of DEVD-caspase
activity by TPEN was prevented at all time points when cells
also received exogenous ZnSO4 (25 mM). Thus, after 5 h of
TPEN treatment in LIM1215 cells (figure 2B,), there was an
increase in DEVD-caspase activity over the control (no TPEN)
of 5.9 U/mg of protein. Similarly, for NCI-H292 cells (figure
2B,), there was a corresponding increase of 5.4 U/mg of protein.
When LIM1215 cells were treated with TPEN in the presence
of 25 mM of ZnSO4, there was a 10-fold reduction to 0.4 U/mg
of protein. Since TPEN can also chelate copper and nickel, it
is possible that some of the responses were due to chelation of
these metal ions. However, our zinc supplementation studies
demonstrated that TPEN was acting by chelating zinc.
The fluorogenic substrate assays, which showed an increase
in DEVD-caspase activity in TPEN-treated cells, could indicate
rises in caspase-3 or caspase-7, both of which can cleave this
substrate. The Western blot in figure 3 confirmed that TPEN
induced caspase-3 activity, as determined by the decrease in the
32-kDa zymogen form (CPP32) of caspase-3. The antibody
used in this blot failed to pick up either of the active subunits
of caspase-3, probably due to the specificity of the antibody
used. The decrease in CPP32 was most evident between 2 and
3 h after addition of TPEN (figure 3A), consistent with the
results of the fluorogenic substrate assay (figure 2B).
Zinc depletion by TPEN induces caspase-6 activation.
CPP32 can be processed to its active form by other caspases,
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Figure 4. Induction of caspase-6 enzymatic activity in TPEN-
treated cells. LIM1215 or NCI-H292 cells were treated with 25 mM
TPEN for varying periods (<6 h). Cell lysates were prepared and as-
sayed for caspase-6 activity with the fluorogenic substrate VEID-AFC.
Data are means of triplicates. Error bars indicate SDs. Typical exper-
iments are shown.
Figure 5. TPEN-induced DNA fragmentation. LIM1215 cells were
treated with varying concentrations of TPEN for 3 h (A) or for varying
times with 25 mM TPEN (B). Lysates were assayed for soluble DNA
fragments. Typical experiment is shown. Data are means of triplicates.
Error bars indicate SDs.
including caspase-6. To determine whether TPEN is activating
caspase-3 by inducing caspase-6, LIM1215 or NCI-H292 cells
were treated with 25 mM TPEN for varying periods. Caspase-
6 activity was monitored by Western blotting to detect the active
p20 subunit (figure 3B) or by a fluorogenic substrate assay with
VEID-AFC. The active p20 subunit of caspase-6 did not in-
crease significantly in the first 2 h after addition of TPEN to
LIM1215 cells but increased steadily after 2 h (figure 3B). Sim-
ilar results were obtained by the enzymatic assay, with increases
in VEID-caspase occurring after 2 h in LIM1215 cells and after
3 h in NCI-H292 cells (figure 4). These observations suggest
that caspase-6 is not significantly involved in the activation of
caspase-3 in zinc-depleted epithelial cells.
Zinc depletion induces DNA fragmentation and apoptosis.
Effects on apoptosis were determined by measuring DNA frag-
mentation and by flow cytometry. Data are shown for LIM1215
cells. DNA fragmentation induced by TPEN displayed a similar
dependence on concentration (figure 5A) and time (figure 5B)
to that of DEVD-caspase activation. The first increase in DNA
fragmentation occurred after 2 h and a large increase occurred
after 3 h and was almost linear up to 6 h. Flow cytometry
analysis with propidium iodide showed a progressive increase
in apoptotic cells, as indicated by appearance of an increasing
fraction of cells with less than 2N DNA content, preceding the
G1 peak on the fluorescence scans (figure 6). Cells containing
hypodiploid DNA increased 1 h after addition of TPEN and
plateaued at 3 h. The discordance between DNA fragmentation
(figure 5B) and flow cytometry (figure 6) for apoptosis may be
due to the presence of necrotic cells and differences between
processing techniques for the two assays. When observed mi-
croscopically, cells treated with TPEN had chromatin conden-
sation (as determined by HE staining), nuclear fragmentation
(as determined by Hoechst dye 33258), and formation of dis-
tinct apoptotic bodies consistent with apoptosis (not shown).
Caspase inhibitors block TPEN-induced caspase-3 activation
but only partially block DNA fragmentation. To determine
whether caspases are involved in the subsequent apoptosis of
TPEN-treated epithelial cells, two specific membrane-permea-
ble peptide inhibitors of caspase-3 were used. zDEVD-fmk is
a specific inhibitor of caspase-3, while zVAD-fmk is an inhibitor
of a broad spectrum of caspases [10]. Both inhibitors completely
inhibited DEVD-caspase activity in TPEN-treated LIM1215
cells (figure 7A), although it was not determined whether the
peptide inhibitors blocked the active caspase-3 or the caspase-
dependent steps leading to activation of caspase-3. Despite the
complete inhibition of DEVD-caspase activity, there was only
partial inhibition of DNA fragmentation, even at higher con-
centrations of inhibitors (figure 7B). Hence DNA fragmenta-
tion in zinc-depleted cells was partially caspase independent.
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Figure 6. TPEN-induced apoptosis measured by flow cytometry.
LIM1215 cells were treated for varying times with 25 mM TPEN. Com-
bined nonadherent and adherent cell populations were washed, fixed,
and analyzed by flow cytometry (see Materials and Methods). Percent
“sub-G1” apoptotic cells are shown on y axis.
Figure 7. Effects of caspase peptide inhibitors on DEVD-caspase
activity and DNA fragmentation. LIM1215 cells were pretreated for
1 h with 10 mM zDEVD-fmk or 25 mM zVAD-fmk before addition of
0 (solid columns) or 25 mM (hatched columns) TPEN for another 3.5
h. Cell lysates were prepared and assayed for DEVD-caspase activity
(A) or soluble DNA fragments (B). Data are means of triplicates from
typical experiment; error bars indicate SDs. Significance was deter-
mined by Student’s t test. prtn, protein.
Although the level of DNA fragmentation in cells treated with
zVAD-fmk appeared to be higher than in control cells, there
was no statistically significant increase ( ).P 1 .05
TPEN induces loss of p21 associated with appearance of p15
and eventually loss of both species. Previous studies from our
laboratory and others identified the cell cycle regulator p21 as
a specific substrate of caspase-3 in cells induced to apoptose
by butyrate and other agents [15–18]. We therefore determined
whether p21 was also cleaved in zinc-depleted cells. LIM1215
cells were treated with 25 mM TPEN for varying time periods,
and lysates were assayed by Western blotting with a p21 mon-
oclonal antibody. This antibody also detected the larger p15
cleavage product of p21 formed by caspase-3–dependent cleav-
age of p21 at D112. Decrease in p21 and appearance of p15 first
occurred 1 h after addition of TPEN (figure 8, track B). By 2
h, most of the p21 had been cleaved, and there was a major
band corresponding to p15. By 4 h, neither p21 nor p15 were
detectable, suggesting further degradation of p15. Similar re-
sults were obtained for the other cell line tested (A549) (data
not shown).
Effects on p21 are mediated, at least in part, by caspase-3
cleavage. A comparison of the time courses of caspase-3 ac-
tivation and p21 degradation in TPEN-treated cells suggests
that p21 loss is mediated by caspase-3. To investigate this fur-
ther, LIM1215 cells were pretreated with zDEVD-fmk (0–100
mM) for 1 h before the addition of 25 mM TPEN for a further
2 h. Lysates were then prepared and assayed by Western blot-
ting with p21. At 50 and 100 mM zDEVD-fmk, there was com-
plete suppression of cleavage of p21 to p15 (data not shown).
Discussion
Enhanced apoptotic cell death in epithelial tissues is a con-
sequence of in vivo zinc deficiency and may play an important
role in the formation of the characteristic vesicular skin lesions
[25], damage to the gastrointestinal lining and associated di-
arrhea [26], and sloughing of the respiratory epithelium. This
study addressed the mechanisms by which depletion of intra-
cellular zinc induces apoptosis of epithelial cells by use of an
in vitro model in which human malignant epithelial cell lines
were treated with the zinc chelator TPEN. This study had three
major conclusions: Apoptosis in zinc-depleted cells proceeds
via a caspase-3–dependent process, there is only a short lag
period (1–2 h) between addition of TPEN and onset of caspase-
3 activation, and activation of caspase-3 is rapidly followed by
loss of p21Waf1/Cip1, first to a 15-kDa fragment and then further
degraded.
Our findings in TPEN-treated cells of (first) an increase in
DEVD-caspase activity, (second) loss of the 32-kDa zymogen
form of caspase-3, and (third) partial suppression of DNA frag-
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Figure 8. Effect of zinc depletion on p21 cleavage. LIM1215 cells
were treated in absence (A) or presence (B) of 25 mM TPEN for varying
time periods. Effects on p21 were determined by Western blotting.
Typical experiment is shown. Position of p21 and cleaved fragment
p15 are indicated by arrows.
mentation by caspase peptide inhibitors (including a specific
inhibitor of caspase-3, zDEVD-fmk), argue for a major role of
caspase-3 in the TPEN-induced apoptosis. This conclusion is
strengthened by the recent study of TPEN-induced cell death
in human renal cell carcinoma cell lines, in which mutant cell
lines lacking caspase-3 were resistant to TPEN-induced apop-
tosis [7]. Since these resistant cell lines also had variable de-
creases in caspase-7, -8, and -10, it cannot be ruled out that
loss of one of these upstream caspases may also have been
important. Caspase-6, the caspase responsible for cleavage of
nuclear lamins [13], was also activated in zinc-depleted cells in
our study, and this caspase may be responsible for the subse-
quent nuclear fragmentation in zinc-depleted cells. Suppression
of TPEN-induced DNA fragmentation by the caspase-3 peptide
inhibitor zDEVD-fmk was only partial, despite complete sup-
pression of DEVD-caspase activity. That other caspases may
substitute for caspase-3 is unlikely since the broad-spectrum
caspase inhibitor zVAD-fmk was also only partially able to
suppress DNA fragmentation. We believe that at least some of
the resulting DNA fragmentation is via a caspase-independent
mechanism, although whether DNA fragmentation also occurs
by nonapoptotic mechanisms cannot be ruled out. The obser-
vations that TPEN lowers intracellular zinc under the condi-
tions used in this study and that zinc supplementation prevents
the effects of TPEN on apoptosis of these cells, suggests that
depletion of zinc is responsible for most, if not all, of the actions
of TPEN on these cells.
We recently reported on the importance of zinc as a regulator
of apoptosis [27]. The mechanism by which intracellular zinc
depletion triggers caspase-3 activation remains unclear. In view
of the short lag period (1–2 h) between addition of TPEN and
onset of caspase-3 activation, zinc must influence a step rela-
tively close to that of caspase-3 activation. Indeed, in primary
tracheobronchial ciliated epithelial cells, zinc is concentrated in
the apical cytoplasm [28], the same region in which the pre-
cursor form of caspase-3 is localized [29]. Caspase-3 activation
involves the proteolytic processing of a 32-kDa zymogen by
other caspases; both caspase-9 [14] and caspase-6 [30] have been
implicated in this processing. It is of interest that both of these
caspases are very sensitive to inhibition by zinc [13, 31, 32].
TPEN might therefore act by stripping zinc from either or both
of these caspases, thus enhancing their activity. We were unable
to show any significant activation of caspase-6 prior to acti-
vation of caspase-3. Caspase-6 was activated in TPEN-treated
cells, but only at time points later than that of caspase-3 ac-
tivation. It is possible that only small amounts of caspase-6 are
required for processing of caspase-3 and that these levels were
too low to be detected by our fluorogenic substrate assay. Ef-
fects of zinc depletion on caspase-9 activity now need to be
determined. Alternatively, zinc may influence the levels of aux-
iliary factors in the activation of caspase-3. Candidates include
members of the Bcl-2 family of proteins, which suppress cas-
pase-3 activation and may be up-regulated by zinc supplemen-
tation [33]. Another candidate may be nitric oxide, since a nitric
oxide synthase inhibitor protects mice from zinc defi-
ciency–induced apoptosis and damage in the gastrointestinal
epithelium [34].
The third major conclusion of this study is that activation
of caspase-3 in zinc-depleted cells is rapidly followed by loss
of the cell-cycle regulator p21Waf1/Cip1. This loss occurs in two
steps: Initially, there is cleavage of p21 to a 15-kDa derivative,
which we [14] and others [15–17] have shown to arise by cas-
pase-3–dependent cleavage of p21 at D112. This cleavage, which
separates the N-terminal domain (that binds to and inhibits the
cyclin-cdk complex) from the C-terminal (that binds to the
nuclear proliferation–associated marker PCNA), results in a
15-kDa fragment that cannot localize in the nucleus but facil-
itates apoptosis by poorly understood mechanisms. After the
initial cleavage of p21, there was complete loss in zinc-depleted
cells. Since the turnover of p21 is regulated by the proteasome
complex of proteases [35], the initial cleavage to p15 may expose
sites that facilitate ubiquitinization and subsequent targeting to
the proteasome. Loss of p21 may result in premature entry of
the cells into S-phase, and apoptotic cell death occurs in some
other forms of apoptosis [36]. Experiments to test the effect of
zinc depletion on apoptosis in cells transfected with a mutant
form of p21 that has an alanine instead of aspartate at position
112 and which will, therefore, be resistant to caspase-dependent
cleavage, should prove informative.
The extent to which in vivo zinc deficiency is associated with
enhanced rates of caspase activation, p21 degradation, and
apoptosis in epithelial tissues needs to be determined. This will
best be answered in the context of experimental zinc deficiency
in animals that will allow these parameters to be correlated
with impaired barrier function and increased rates of infections.
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